2017
DOI: 10.1507/endocrj.ej16-0500
|View full text |Cite
|
Sign up to set email alerts
|

Aldosterone excess may inhibit insulin secretion: A comparative study on glucose metabolism pre- and post-adrenalectomy in patients with primary aldosteronism

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
17
1
3

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 27 publications
(27 citation statements)
references
References 27 publications
6
17
1
3
Order By: Relevance
“…In the present study, the subgroup analysis (comprising~28% of the study subjects) showed that HOMA-β was lower in PA patients than in matched controls. These findings are in agreement with data from clinical studies showing that PA patients have lower first phase insulin response, HOMA-β, and C-peptide concentration [23,25] and insulin secretion increased after ADX in PA patients [31], and those from in vitro and animal studies showing that aldosterone reduces insulin secretion. However, several clinical studies conducted in Caucasians have shown greater IR in PA [21,22,26].…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…In the present study, the subgroup analysis (comprising~28% of the study subjects) showed that HOMA-β was lower in PA patients than in matched controls. These findings are in agreement with data from clinical studies showing that PA patients have lower first phase insulin response, HOMA-β, and C-peptide concentration [23,25] and insulin secretion increased after ADX in PA patients [31], and those from in vitro and animal studies showing that aldosterone reduces insulin secretion. However, several clinical studies conducted in Caucasians have shown greater IR in PA [21,22,26].…”
Section: Discussionsupporting
confidence: 91%
“…Previous clinical studies show discrepant results about comparisons of the effects of ADX and MRA therapy on glucose metabolism in PA [21,24,29,30]. Although one study showed no differences in decreased IR between the treatment modality (ADX vs. MRA therapy) [21], other clinical studies showed improved glucose metabolism in APA patients after ADX, but not in BAH patients after MRA therapy [24,29,30] and increased insulin secretion in APA patients after ADX [23,31]. However, previous clinical studies comparing the effects of ADX and MRA therapy used only small numbers of patients (N = 9-61), and therefore definitive conclusions cannot be drawn from these [11].…”
Section: Introductionmentioning
confidence: 99%
“…INTRODUÇÃO | 20 níveis de glicose no sangue. Segundo a OMS, um a cada três adultos estão com sobrepeso e uma a cada dez pessoas são obesas, resultado do excesso de consumo de dieta não saudável e falta de atividade física, contribuindo para o aumento dos casos de diabetes (Who, 2016 (Whiting et al, 2011;Guariguata, 2012;I.D.F., 2012;2017 (De Vriese et al, 2000) e a produção de espécies reativas de oxigênio (ERO) (Gryglewski et al, 1986). Adicionalmente, observa-se aumento de fatores vasoconstritores (Yanagisawa et al, 1988;Schneider et al, 2002).…”
Section: Diabetes Mellitusunclassified
“…A ativação de macrófagos em camundongos db/db prejudica a cicatrização de feridas, aumenta os marcadores de inflamassoma e reduz a expressão de inibidores de inflamassoma endógeno, como PI-9 e caspase-12. Além disso, o transplante de células derivadas da medula óssea de camundongos nocaute para NLRP3 ou caspase-1 para camundongos db/db melhora a cicatrização de feridas e a participação de macrófagos no processo de cicatrização (Catena et al, 2006;Tsurutani et al, 2017), evidenciando, assim, a associação entre diabetes mellitus e aldosterona. Em pacientes com hipertensão arterial, foi demonstrada relação direta entre aldosterona, resistência à insulina e hiperinsulinemia (Colussi et al, 2007).…”
Section: Aldosterona Aumenta a Atividade Da Caspase-1 Em Macrófagos Dunclassified
See 1 more Smart Citation